CEBPA and acute myeloid leukemia: Of AML patients with CEBPA mutations (n = 17), 12 cases had variants outside the bZIP domain (70.6%, CEBPAmutoutbZIP), whereas the remaining cases showed bZIP mutations (29.4%; 3 missense mutations, CEBPAmutbZIPmis;1 frameshift, CEBPAmutbZIPfs; 1 inframe, CEBPAmutbZIPinfr).